Post by
robert345 on Jun 03, 2022 1:44pm
Hemostemix Inc. $HMTXF stock evaluation
Hemostemix Inc. (OTC: $HMTXF) is a clinical-stage biotech company listed over OTC, having a market cap of 16.27M. It started at an open share price of $0.2474+ The stock analysis of 52 weeks is marked as 0.0991(high) and 0.3279(low).